International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

Date
2019
Author
Caroppo, Francesca
Yavuz, Akif
Merante, Serena
Elena, Chiara
Illerhaus, Anja
Perkins, Cecelia
Bonifacio, Massimiliano
Kilbertus, Alex J.
Sperr, Wolfgang R.
Kundi, Michael
Alvarez-Twose, Ivan
van Anrooij, Bjorn
Elberink, Joanna N. G. Oude
Gorska, Aleksandra
Niedoszytko, Marek
Gleixner, Karoline V.
Hadzijusufovic, Emir
Zanotti, Roberta
Bonadonna, Patrizia
Doubek, Michael
Hagglund, Hans
Panse, Jens
Sabato, Vito
Bretterklieber, Agnes
Niederwieser, Dietger
Breynaert, Christine
Hartmann, Karin
Triggiani, Massimo
Nedoszytko, Boguslaw
Reiter, Andreas
Orfao, Alberto
Hermine, Olivier
Gotlib, Jason
Arock, Michel
Kluin-Nelemans, Hanneke C.
Valent, Peter
Fuchs, David
Zink, Alexander
Brockow, Knut
Fortina, Anna Belloni
Jawhar, Mohamad
Parente, Roberta
von Bubnoff, Nikolas
Shoumariyeh, Khalid
Metadata
Show full item record
Abstract
Background The WHO classification separates mastocytosis into distinct variants, but prognostication remains a clinical challenge. The aim of this study was to improve prognostication for patients with mastocytosis.
URI
http://hdl.handle.net/20.500.12627/65472
https://doi.org/10.1016/s2352-3026(19)30166-8
Collections